Total Payments
$151,057
2023 Payments
$34.59
Companies
46
Transactions
929
Medicare Patients
3,719
Medicare Billing
$783,149
Payment Breakdown by Category
Other$123,971 (82.1%)
Food & Beverage$15,553 (10.3%)
Travel$8,602 (5.7%)
Consulting$2,900 (1.9%)
Education$30.02 (0.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $123,971 | 104 | 82.1% |
| Food and Beverage | $15,553 | 762 | 10.3% |
| Travel and Lodging | $8,602 | 51 | 5.7% |
| Consulting Fee | $2,900 | 8 | 1.9% |
| Education | $30.02 | 4 | 0.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| PFIZER INC. | $48,961 | 57 | $0 (2020) |
| Teva Pharmaceuticals USA, Inc. | $26,088 | 96 | $0 (2022) |
| Allergan, Inc. | $25,025 | 120 | $0 (2022) |
| Biohaven Pharmaceuticals, Inc. | $19,462 | 54 | $0 (2021) |
| E.R. Squibb & Sons, L.L.C. | $9,323 | 16 | $0 (2019) |
| ABBVIE INC. | $8,157 | 89 | $0 (2023) |
| Biohaven Pharmaceutical Holding Company Ltd. | $4,014 | 12 | $0 (2022) |
| Biogen, Inc. | $1,356 | 28 | $0 (2022) |
| Acorda Therapeutics, Inc | $823.58 | 42 | $0 (2022) |
| GENZYME CORPORATION | $808.80 | 47 | $0 (2022) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2023 | $34.59 | 2 | ABBVIE INC. ($17.35) |
| 2022 | $5,878 | 66 | Biohaven Pharmaceutical Holding Company Ltd. ($4,014) |
| 2021 | $34,540 | 212 | Biohaven Pharmaceuticals, Inc. ($19,462) |
| 2020 | $22,449 | 136 | Allergan, Inc. ($13,565) |
| 2019 | $22,108 | 185 | Teva Pharmaceuticals USA, Inc. ($9,750) |
| 2018 | $21,400 | 178 | PFIZER INC. ($6,694) |
| 2017 | $44,647 | 150 | PFIZER INC. ($29,562) |
All Payment Transactions
929 individual payment records from CMS Open Payments — Page 1 of 38
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 11/14/2023 | ABBVIE INC. | UBRELVY (Drug), BOTOX | Food and Beverage | In-kind items and services | $17.35 | General |
| Category: NEUROSCIENCE | ||||||
| 03/06/2023 | Boston Scientific Corporation | WaveWriter Alpha Prime 16 (Device) | Food and Beverage | In-kind items and services | $17.24 | General |
| Category: WaveWriter Alpha_NMD | ||||||
| 10/03/2022 | ABBVIE INC. | QULIPTA (Drug) | Food and Beverage | In-kind items and services | $10.72 | General |
| Category: NEUROSCIENCE | ||||||
| 09/13/2022 | ABBVIE INC. | BOTOX (Biological) | Food and Beverage | In-kind items and services | $9.52 | General |
| Category: NEUROSCIENCE | ||||||
| 08/31/2022 | ABBVIE INC. | BOTOX (Biological) | Food and Beverage | In-kind items and services | $10.57 | General |
| Category: NEUROSCIENCE | ||||||
| 08/18/2022 | ABBVIE INC. | QULIPTA (Drug) | Food and Beverage | In-kind items and services | $12.87 | General |
| Category: NEUROSCIENCE | ||||||
| 08/10/2022 | ABBVIE INC. | QULIPTA (Drug) | Food and Beverage | In-kind items and services | $19.71 | General |
| Category: NEUROSCIENCE | ||||||
| 08/01/2022 | ABBVIE INC. | QULIPTA (Drug) | Food and Beverage | In-kind items and services | $2.94 | General |
| Category: NEUROSCIENCE | ||||||
| 07/27/2022 | ABBVIE INC. | BOTOX (Biological) | Food and Beverage | In-kind items and services | $9.28 | General |
| Category: NEUROSCIENCE | ||||||
| 06/27/2022 | ABBVIE INC. | QULIPTA (Drug) | Food and Beverage | In-kind items and services | $10.40 | General |
| Category: NEUROSCIENCE | ||||||
| 06/27/2022 | ABBVIE INC. | QULIPTA (Drug) | Food and Beverage | In-kind items and services | $9.97 | General |
| Category: NEUROSCIENCE | ||||||
| 06/21/2022 | Amneal Pharmaceuticals LLC | RYTARY (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | In-kind items and services | $53.45 | General |
| Category: NEUROLOGY | ||||||
| 06/13/2022 | Alexion Pharmaceuticals, Inc. | ULTOMIRIS (Biological) | Food and Beverage | In-kind items and services | $15.13 | General |
| Category: Rare Disease | ||||||
| 06/13/2022 | ABBVIE INC. | QULIPTA (Drug) | Food and Beverage | In-kind items and services | $9.95 | General |
| Category: NEUROSCIENCE | ||||||
| 05/18/2022 | ABBVIE INC. | BOTOX (Biological) | Food and Beverage | In-kind items and services | $8.31 | General |
| Category: NEUROSCIENCE | ||||||
| 05/16/2022 | ABBVIE INC. | QULIPTA (Drug) | Food and Beverage | In-kind items and services | $11.45 | General |
| Category: NEUROSCIENCE | ||||||
| 05/12/2022 | Novartis Pharmaceuticals Corporation | KESIMPTA (Drug), MAYZENT | Food and Beverage | In-kind items and services | $19.62 | General |
| Category: NEUROSCIENCE | ||||||
| 05/12/2022 | ABBVIE INC. | BOTOX (Biological) | Food and Beverage | In-kind items and services | $8.77 | General |
| Category: NEUROSCIENCE | ||||||
| 05/11/2022 | Amneal Pharmaceuticals LLC | RYTARY (Drug) | Food and Beverage | In-kind items and services | $15.85 | General |
| Category: NEUROLOGY | ||||||
| 05/10/2022 | Biohaven Pharmaceutical Holding Company Ltd. | NURTEC ODT (Drug) | Food and Beverage | In-kind items and services | $17.47 | General |
| Category: PRIMARY CARE | ||||||
| 05/09/2022 | ABBVIE INC. | QULIPTA (Drug) | Food and Beverage | In-kind items and services | $12.72 | General |
| Category: NEUROSCIENCE | ||||||
| 05/03/2022 | ABBVIE INC. | BOTOX (Biological) | Food and Beverage | In-kind items and services | $17.55 | General |
| Category: HYPERHYDROSIS | ||||||
| 04/21/2022 | Novartis Pharmaceuticals Corporation | KESIMPTA (Drug), MAYZENT | Food and Beverage | In-kind items and services | $16.34 | General |
| Category: NEUROSCIENCE | ||||||
| 04/19/2022 | ABBVIE INC. | QULIPTA (Drug) | Food and Beverage | In-kind items and services | $11.41 | General |
| Category: NEUROSCIENCE | ||||||
| 04/11/2022 | Novartis Pharmaceuticals Corporation | KESIMPTA (Drug), MAYZENT | Food and Beverage | In-kind items and services | $19.04 | General |
| Category: NEUROSCIENCE | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 4 | 969 | 1,234 | $194,095 | $119,368 |
| 2022 | 10 | 798 | 978 | $183,167 | $89,396 |
| 2021 | 13 | 949 | 17,220 | $483,350 | $197,254 |
| 2020 | 18 | 1,003 | 58,742 | $978,260 | $377,131 |
Total Patients
3,719
Total Services
78,174
Medicare Billing
$783,149
Procedure Codes
50
All Medicare Procedures & Services
50 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 95886 | Needle measurement of electrical activity in arm or leg muscles, complete study | Office | 2023 | 486 | 737 | $82,305 | $50,869 | 61.8% |
| 95910 | Nerve conduction, 7-8 studies | Office | 2023 | 245 | 254 | $51,670 | $31,622 | 61.2% |
| 95911 | Nerve conduction, 9-10 studies | Office | 2023 | 200 | 205 | $50,050 | $30,414 | 60.8% |
| 95912 | Nerve conduction, 11-12 studies | Office | 2023 | 38 | 38 | $10,070 | $6,463 | 64.2% |
| 95886 | Needle measurement of electrical activity in arm or leg muscles, complete study | Office | 2022 | 266 | 418 | $48,220 | $30,024 | 62.3% |
| 95911 | Nerve conduction, 9-10 studies | Office | 2022 | 112 | 115 | $29,436 | $17,910 | 60.8% |
| 95910 | Nerve conduction, 7-8 studies | Office | 2022 | 118 | 119 | $24,815 | $15,385 | 62.0% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 109 | 113 | $15,820 | $7,139 | 45.1% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2022 | 74 | 82 | $15,416 | $7,103 | 46.1% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Facility | 2022 | 36 | 41 | $6,888 | $2,604 | 37.8% |
| 95912 | Nerve conduction, 11-12 studies | Office | 2022 | 14 | 14 | $5,095 | $2,477 | 48.6% |
| 64615 | Injection of chemical for paralysis of facial and neck nerve muscles on both sides of face | Facility | 2022 | 33 | 40 | $20,000 | $2,322 | 11.6% |
| 95913 | Nerve conduction, 13 or more studies | Office | 2022 | 12 | 12 | $7,560 | $2,199 | 29.1% |
| 95909 | Nerve conduction, 5-6 studies | Office | 2022 | 11 | 11 | $2,065 | $1,119 | 54.2% |
| 95810 | Sleep study in sleep lab (6 years or older) | Facility | 2022 | 13 | 13 | $7,852 | $1,115 | 14.2% |
| J0585 | Injection, onabotulinumtoxina, 1 unit | Office | 2021 | 34 | 7,800 | $93,600 | $37,865 | 40.5% |
| 99215 | Established patient outpatient visit, total time 40-54 minutes | Office | 2021 | 200 | 344 | $64,672 | $37,428 | 57.9% |
| J0588 | Injection, incobotulinumtoxin a, 1 unit | Office | 2021 | 37 | 8,100 | $81,000 | $32,743 | 40.4% |
| 95886 | Needle measurement and recording of electrical activity of muscles of arm or leg complete study | Office | 2021 | 177 | 286 | $40,040 | $20,797 | 51.9% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 165 | 221 | $30,940 | $18,603 | 60.1% |
| 95913 | Nerve transmission studies, 13 or more studies | Office | 2021 | 54 | 54 | $34,020 | $11,189 | 32.9% |
| 95910 | Nerve transmission studies, 7-8 studies | Office | 2021 | 53 | 53 | $18,285 | $6,922 | 37.9% |
| 64615 | Injection of chemical for destruction of facial and neck nerve muscles on both sides of face | Office | 2021 | 36 | 70 | $35,000 | $6,365 | 18.2% |
| 64615 | Injection of chemical for destruction of facial and neck nerve muscles on both sides of face | Facility | 2021 | 33 | 68 | $34,000 | $6,050 | 17.8% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Facility | 2021 | 40 | 73 | $12,264 | $5,321 | 43.4% |
About Dr. Justin Graff, M.D
Dr. Justin Graff, M.D is a Neurology healthcare provider based in Tupelo, Mississippi. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 08/23/2005. The National Provider Identifier (NPI) number assigned to this provider is 1427041664.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Justin Graff, M.D has received a total of $151,057 in payments from pharmaceutical and medical device companies, with $34.59 received in 2023. These payments were reported across 929 transactions from 46 companies. The most common payment nature is "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program" ($123,971).
As a Medicare-enrolled provider, Graff has provided services to 3,719 Medicare beneficiaries, totaling 78,174 services with total Medicare billing of $783,149. Data is available for 4 years (2020–2023), covering 50 distinct procedure/service records.
Ad
Practice Information
- Specialty Neurology
- Location Tupelo, MS
- Active Since 08/23/2005
- Last Updated 12/30/2010
- Taxonomy Code 2084N0400X
- Entity Type Individual
- NPI Number 1427041664
Products in Payments
- ELIQUIS (Drug) $58,285
- NURTEC ODT (Drug) $23,476
- UBRELVY (Drug) $21,750
- AJOVY (Drug) $16,209
- NAMZARIC (Drug) $10,004
- AJOVY (Biological) $9,222
- TYSABRI (Biological) $577.13
- VNS Therapy (Device) $568.88
- BOTOX (Biological) $567.48
- INBRIJA (Drug) $529.57
- LEMTRADA (Drug) $473.87
- OCREVUS (Biological) $470.28
- Aimovig (Biological) $462.73
- AUSTEDO (Drug) $458.08
- AUBAGIO (Drug) $362.81
- APTIOM (Drug) $328.96
- ACTIVA (Device) $318.72
- Radicava (Drug) $302.42
- AMPYRA (Drug) $294.01
- QULIPTA (Drug) $274.27
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Neurology Doctors in Tupelo
Stephen Landy, Md, MD
Neurology — Payments: $2.1M
Neurology $2.1M
Mark Fletcher, M.d, M.D
Neurology — Payments: $83,368
Neurology $83,368
Samuel Newell, M.d, M.D
Neurology — Payments: $11,419
Neurology $11,419
Donna Harrington, M.d, M.D
Neurology — Payments: $8,705
Neurology $8,705
William Oakes, M.d, M.D
Neurology — Payments: $5,618
Neurology $5,618
Esther Fischer, M.d, M.D
Neurology — Payments: $2,084
Neurology $2,084